No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alzheimer Disease / immunology
-
Alzheimer Disease / metabolism
-
Alzheimer Disease / prevention & control*
-
Alzheimer Disease / therapy*
-
Alzheimer Vaccines / adverse effects
-
Alzheimer Vaccines / immunology*
-
Alzheimer Vaccines / therapeutic use*
-
Amyloid / antagonists & inhibitors
-
Amyloid / chemistry
-
Amyloid / immunology
-
Amyloid / metabolism
-
Amyloid beta-Peptides / adverse effects
-
Amyloid beta-Peptides / antagonists & inhibitors*
-
Amyloid beta-Peptides / chemistry
-
Amyloid beta-Peptides / immunology
-
Amyloid beta-Peptides / metabolism
-
Amyloid beta-Peptides / therapeutic use
-
Animals
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Clinical Trials as Topic
-
Humans
-
Immunoglobulins, Intravenous / economics
-
Immunoglobulins, Intravenous / immunology*
-
Immunoglobulins, Intravenous / therapeutic use*
-
Mice
-
tau Proteins / antagonists & inhibitors
-
tau Proteins / chemistry
-
tau Proteins / metabolism
Substances
-
AN-1792
-
Alzheimer Vaccines
-
Amyloid
-
Amyloid beta-Peptides
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulins, Intravenous
-
tau Proteins
-
bapineuzumab